Freibaum Brian D, Counter Christopher M
Departments of Pharmacology and Cancer Biology and Radiation Oncology, Duke University Medical Center, Durham, NC 27710, USA.
J Biol Chem. 2008 Aug 29;283(35):23671-6. doi: 10.1074/jbc.M800388200. Epub 2008 Jul 1.
hSnm1B is member of the SNM family of exonucleases involved in DNA processing and is known to be localized to telomeres via binding to the telomere-binding protein TRF2. Here we demonstrate that the C terminus of hSnm1B facilitates the concentration of hSnm1B on telomeres by promoting ubiquitin-mediated degradation of hSnm1B that is not localized to telomeres, as well as by blocking protein degradation and fostering localization to telomeres via binding of TRF2. Finally, a mutant of hSnm1B stabilized independently of exogenous TRF2-induced cell death. Taken together, we speculate that sequestering hSnm1B at telomeres by a combination of stabilizing the protein when bound to telomeres and degrading it when not bound to telomeres may be a means to prevent potentially lethal effects of unregulated hSnm1B activity.
hSnm1B是参与DNA加工的核酸外切酶SNM家族的成员,已知它通过与端粒结合蛋白TRF2结合而定位于端粒。在这里,我们证明hSnm1B的C末端通过促进未定位到端粒的hSnm1B的泛素介导降解,以及通过阻断蛋白质降解并通过TRF2的结合促进其定位到端粒,从而促进hSnm1B在端粒上的聚集。最后,hSnm1B的一个突变体独立于外源性TRF2诱导的细胞死亡而稳定。综上所述,我们推测,通过结合端粒时稳定蛋白质和未结合端粒时降解蛋白质的方式将hSnm1B隔离在端粒上,可能是一种防止hSnm1B活性失控产生潜在致死效应的手段。